U.S. market Closed. Opens in 1 day 43 minutes

CPHI | China Pharma Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-06-302003-06-302002-06-30
Revenue7.01M8.10M9.64M10.87M10.92M12.33M13.21M15.57M20.35M22.13M32.81M54.51M81.17M74.39M61.70M50.97M33.19M21.84M8.66M23.27K110.08K37.49K
Cost of Revenue7.29M8.60M9.29M8.91M9.44M10.36M10.74M12.35M18.89M19.47M29.59M40.43M52.18M44.11M36.05M25.68M17.62M11.75M4.17M47.68KN/AN/A
Gross Profit-281.08K-493.92K349.27K1.95M1.48M1.97M2.47M3.22M1.46M2.67M3.22M14.08M28.99M30.28M25.65M25.29M15.57M10.10M4.49M-24.41K110.08K37.49K
Operating Expenses2.47M3.15M3.46M4.42M4.87M-12.42M-21.15M-11.37M-15.76M-41.43M-21.83M-8.17M6.96M6.09M3.04M5.56M3.32M1.47M247.03K92.96K265.72K752.32K
Selling, General & Admin2.25M2.87M3.15M4.04M4.64M5.77M6.87M7.39M16.34M36.42M16.44M7.28M7.16M5.58M4.85M5.56M3.32M1.47M247.03K92.96K265.72K752.32K
Research & Development240.08K185.86K318.96K377.96K229.64K172.38K90.47K365.97K961.90K2.80M1.68M438.66KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/A93.85KN/A115.19B7.58TN/A4.83TN/AN/AN/AN/A1.46T-193.59K505.22K-1.82M1.85BN/AN/AN/AN/AN/AN/A
Operating Income-2.75M-3.55M-3.12M-2.46M-3.39M-3.97M-4.50M-4.19M-14.20M-36.55M-14.91M6.50M22.03M24.66M22.61M19.73M12.25M8.62M4.24M-117.37K-155.64K-714.83K
Other Expenses / Income-327.00K-423.86K-538.97K-288.48K-17.31M-6.89M-14.66M-4.68M-1.15M-2.93M-340.24K-896.53K686.27K1.44M-119.95K-189.04K405.43K-36.41K-192.16KN/A-386.92K450.72K
Before Tax Income-3.08M-3.97M-3.40M-2.87M-20.70M-10.86M-19.15M-8.87M-15.35M-39.47M-18.95M5.60M22.71M26.10M22.49M19.54M12.66M8.59M4.05M-117.37K-180.17K-1.10M
Income Tax ExpensesN/A6.25M542.00K294.16K321.72K109.99K122.63K308.18K60.44K77.04K1.06M983.92K3.44M2.69M2.26M1.71M-162.87K-217.96K252.10K762.66K95.25K678.89K
Net Income-3.08M-10.22M-3.94M-3.16M-21.02M-10.75M-19.28M-9.18M-15.41M-26.05M-20.01M4.62M19.27M23.41M20.23M17.83M12.82M8.59M3.80M-504.29K-226.37K-1.10M
Interest Expenses333.60K434.62K542.00K294.16K321.72K451.26K539.33K849.56K1.17M785.80K348.70K308.38K255.20K168.26K154.18K131.03K237.40K145.88K186.45K5.59K5.59K49.85K
Basic Shares Outstanding3.38M5.26M4.61M4.36M4.36M4.36M4.36M4.36M4.36M4.35M4.35M4.36M4.35M4.33M4.23M4.02M3.70M3.47M1.13M1.13M653.88K566.36K
Diluted Shares Outstanding3.38M5.26M4.61M4.36M4.36M4.36M4.36M4.36M4.36M4.36M4.36M4.36M4.35M4.35M4.23M4.02M3.73M3.47M1.13M1.13M653.88K566.36K
EBITDA8.44K-837.69K230.34K106.85K-17.45M-7.15M-15.32M-4.95M-10.58M-36.90M-16.99M7.37M24.14M27.77M24.02M20.39M12.67M9.02M4.49M768.15K386.82K-383.44K
EBITDA Margin0.12%-10.34%2.39%0.98%-159.75%-57.99%-115.98%-31.77%-51.99%-166.72%-51.77%13.53%29.74%37.34%38.93%40.01%38.19%41.30%51.91%3,300.32%351.40%-1,022.79%
EBIT-2.75M-3.54M-2.86M-2.57M-20.38M-10.19M-18.62M-8.02M-14.18M-25.18M-18.60M5.91M22.97M26.27M22.65M19.67M12.89M8.52M4.24M263.96K-125.52K-375.39K
EBIT Margin-39.15%-43.66%-29.64%-23.67%-186.57%-82.63%-140.90%-51.54%-69.67%-113.78%-56.69%10.84%28.30%35.31%36.71%38.60%38.85%38.98%48.95%1,134.09%-114.02%-1,001.31%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-06-302003-06-302002-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙